Previous studies demonstrated that serum SALL4 mRNA levels in CRC patients correlated significantly with the degree of tumor invasion and differentiation with high sensitivity and specificity (96% and 95%, respectively), according to ROC analysis [48]. The gene discussed is SALL4; the disease is neoplasm.